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Abstract
Background: The consumption of high levels of industrial trans fatty acids (TFA) has been related to cardiovascular disease,
diabetes and sudden cardiac death but the causal mechanisms are not well known. In this study, NMR and LC-MS
untargeted metabolomics has been used as an approach to explore the impact of TFA intake on plasma metabolites.
Methodology/Principal Findings: In a double-blinded randomized controlled parallel-group study, 52 overweight
postmenopausal women received either partially hydrogenated soybean oil, providing 15.7 g/day of TFA (trans18:1) or
control oil with mainly oleic acid for 16 weeks. Subsequent to the intervention period, the subjects participated in a 12-week
dietary weight loss program. Before and after the TFA intervention and after the weight loss programme, volunteers
participated in an oral glucose tolerance test. PLSDA revealed elevated lipid profiles with TFA intake. NMR indicated up-
regulated LDL cholesterol levels and unsaturation. LC-MS profiles demonstrated elevated levels of specific polyunsaturated
(PUFA) long-chain phosphatidylcholines (PCs) and a sphingomyelin (SM) which were confirmed with a lipidomics based
method. Plasma levels of these markers of TFA intake declined to their low baseline levels after the weight loss program for
the TFA group and did not fluctuate for the control group. The marker levels were unaffected by OGTT.
Conclusions/Significance: This study demonstrates that intake of TFA affects phospholipid metabolism. The preferential
integration of trans18:1 into the sn-1 position of PCs, all containing PUFA in the sn-2 position, could be explained by a
general up-regulation in the formation of long-chain PUFAs after TFA intake and/or by specific mobilisation of these fats
into PCs. NMR supported these findings by revealing increased unsaturation of plasma lipids in the TFA group. These
specific changes in membrane lipid species may be related to the mechanisms of TFA-induced disease but need further
validation as risk markers.
Trial registration: Registered at clinicaltrials.gov as NCT00655902.
Citation: Gu¨rdeniz G, Rago D, Bendsen NT, Savorani F, Astrup A, et al. (2013) Effect of trans Fatty Acid Intake on LC-MS and NMR Plasma Profiles. PLoS ONE 8(7):
e69589. doi:10.1371/journal.pone.0069589
Editor: Matej Oresic, Governmental Technical Research Centre of Finland, Finland
Received January 2, 2013; Accepted June 8, 2013; Published July 29, 2013
Copyright:  2013 Gu¨rdeniz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is carried out as a part of the research program of the Danish Obesity Research Centre (DanORC, www.danorc.dk), funded by the Danish
Strategic Research Council and also supported by Nordic Centre of Excellence (NCoE) programme ‘‘Systems biology in controlled dietary interventions and cohort
studies—SYSDIET, P no. 070014’’ (www.sysdiet.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gozg@life.ku.dk
Introduction
Industrially produced trans fatty acids (TFA) are formed by
partial hydrogenation of vegetable oil that changes cis configura-
tion of double bond(s) to trans, resulting in solid fat for use in
margarines and shortenings, and for commercial cooking, and
manufacturing processes. Partially hardened oils are appealing for
food industry owing to their properties such as long shelf life, their
stability during deep-frying and their semi-solidity. However,
consumption of TFA in the human diet has been associated with
an increased risk of developing cardiovascular disease [1,2],
diabetes [3], and sudden death from cardiac causes [4]. TFA has
now been banned in a few countries, including Austria, Denmark,
Hungary, Sweden, and Switzerland as well as in California and in
the New York municipality in the USA. Denmark was the first
country where the background level of TFA exposure was
minimized because the industry after the ban in 2004 succeeded
in removing these fats from more than 90% all marketed products.
However, this is not the situation in many other countries and
studies to further document and understand the causes of TFA
mediated coronary heart disease (CHD) risk are therefore still
needed. This risk has been linked to the impact of TFA on
lipoprotein metabolism, inflammation, and endothelial function
[5]. It has been well documented that TFA intake increases low-
density lipoprotein (LDL) cholesterol, reduces high-density lipo-
protein (HDL) cholesterol, and increases the risk of cardiovascular
disease [6,7]. Nevertheless, the incidence of CHD reported in
prospective studies as a result of TFA exposure has been greater
than that predicted by increased serum lipids or inflammation
alone. Thus, the observed associations between TFA consumption
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and cardiovascular disease events cannot be explained only by
changes in lipoprotein levels, triglycerides, apolipoprotein (Apo)
B/ApoAI ratio and C-reactive protein [8], implying that the
mechanisms behind the adverse effects of TFAs are not fully
understood. TFA exposure has also been associated with a higher
risk of fatal ischemic heart disease [9] and sudden cardiac death
[10]. Although the potential mechanism between TFA and sudden
cardiac death is unclear, some have suggested that TFA may
modulate cardiac membrane ion channel function [11] or have
proarrhythmic properties, affecting cardiovascular electrophysiol-
ogy [2].
Some evidence also pointed to a possible effect of TFA on
obesity. A dietary 16-week intervention study was conducted here
in 2008 by Bendsen et al. [13] to examine the effect of a high
intake of industrially produced TFA (trans18:1) compared to the cis
analog (cis18:1) on central obesity and insulin sensitivity. The low
TFA background in Denmark made it feasible to conduct a TFA
intervention against a clean background in the control group to
unambiguously assess any shorter-term effects on central fat
deposition or other risk markers of CHD. However, the study did
not provide evidence for effects on obesity development. In order
to search for new hypotheses and fill the gap between TFA intake
and its detrimental health impacts, we selected an untargeted
metabolomics approach to profile plasma samples from this study.
Metabolic profiling allows semiquantification of hundreds of
metabolites in blood samples and might provide a unique insight
into the potential underlying mechanisms. Many studies have
demonstrated metabolomics as a powerful tool to understand
responses of individuals with respect to their gene expression or
alterations in their lifestyles and diets [12]. The application of
liquid chromatography mass spectrometry (LC-MS) and nuclear
magnetic resonance (NMR) in metabolomics for measurement of a
wide range of metabolites in various biofluids has been well
established. NMR provides high reproducibility and is a powerful
tool in terms of quantification, whereas LC-MS is more sensitive,
allowing detection of a larger number of chemical compounds,
albeit with lower reproducibility.
Our results from the untargeted metabolomics analysis of the
TFA intervention study revealed an increased presence during
TFA intake of membrane-derived, specific long chain polyunsat-
urated fatty acid (PUFA)-containing PCs and a SM, suggesting the
possibility of using these compounds as individual markers of TFA
integration into plasma membranes.
Materials and Methods
Subjects
A total of 64 volunteers were assessed for eligibility and 52
healthy, moderately overweight (body mass index between 25 and
32 kg m22), normolipidemic (LDL-C below 6 mmol/L) postmen-
opausal women, between 45 to 70 years of age, were recruited in
this study. Detailed description of participant recruitment and
enrolment, inclusion and exclusion criteria, randomization and
compliance has been published previously [13]. CONSORT flow
diagram displaying subjects recruited into the dietary intervention
has been in given Figure S1.
Study Design
The dietary intervention study had a randomized, double-blind,
parallel design. The clinical trial protocol is given as supporting
information (Protocol S1). The subjects were randomized by strata
of waist circumference with a cut-off at 96 cm to assure that both
strata were equally represented in the two groups. Randomization
numbers from a pre-defined list were provided by a third party to
the kitchen who delivered bread rolls differing in their TFA
content to the subjects. Subjects were given 26 g/d of partially
hydrogenated soybean oil with approximately 60% trans fats (TFA
group; n = 25) or 50/50% mix of palm oil and high oleic sunflower
oil as the control oil (CTR group; n = 27) for 16 weeks. Both test
oils were supplied by Aarhus Karlshamn, Aarhus C, Denmark.
The fatty acid composition in the oils has been described
elsewhere [13]. Briefly, the two fats differed in the content of
TFA (18:1 trans-9, 18:1 trans-8, 18:1 trans-7), palmitic (16:0), oleic
(18:1 cis-9) and linoleic acids (18:2 cis-6). The fats were
incorporated into bread rolls providing a total of 600 kcal/d (41
E% from fat), equivalent to 28% of the subjects’ energy
requirements on average. Frozen rolls were handed out to the
subjects every 1–4 weeks from the department for consumption at
home.
The women visited the department for four examinations
during the intervention: at screening (1–8 weeks prior to baseline),
baseline (w0), mid-intervention (week 8) and at the end of
treatment (w16). In addition, the subjects attended the department
for control weighing at weeks 4 and 12. Subjects were instructed to
maintain their habitual activity level throughout the dietary
intervention period. Subsequent to the dietary intervention period,
the subjects participated in a 12-week (w28) dietary weight loss
program. The blood samples for metabolomics analysis were
collected only at w0, w16 and w28.
Dietary intake was measured using 3-day weighed food records
at baseline and in the last week of the intervention. The only
significant dietary differences between diet groups during the
intervention were the contributions of energy from monounsatu-
rated cis-fatty acids (MUFA) and TFA, indicating that the diets
were overall comparable apart from the cis/trans fatty acid
composition. The intake of TFA was higher (7.060.2 E% [mean
6 SEM] vs. 0.360.0 E%) and the intake of cis-MUFA was lower
(10.360.4 E% vs. 13.460.8 E%) in the TFA group compared with
the CTR group [13]. The trial was registered at clinicaltrials.gov
as NCT00655902.
Ethics statement
The subjects were given both verbal and written information,
whereupon all gave written consent. The study was carried out at
the Department of Nutrition, Exercise and Sport, University of
Copenhagen, Frederiksberg, Denmark, between April 2008 and
March 2009 and was approved by the Municipal Ethical
Committee of The Capital Region of Denmark in accordance
with the Helsinki-II declaration (H-B_2007-089). A copy of the
document issued by ethical committee, confirming your study was
considered and approved was included as supporting information
(Document S1). Subjects received 900 US$ as compensation on
completion of all the tests. This level of compensation is customary
in Denmark for participation in longer-term demanding trials to
cover transportation, discomfort, and the time spent but is taxed at
a level of approximately 50%. The overweight volunteers were
further offered a free 3-months weight loss programme. With the
weight loss programme we aimed to reverse the putatively
unbeneficial effect of the trans-fat, and thereby we anticipated
that the subjects would be healthier after than before participation
in the study.
Blood sampling
Prior to each visit, the subjects were told to fast for at least
10 hours (except for 0.5 L water). They were instructed to avoid
alcohol consumption and vigorous exercise on the day before and
to consume similar carbohydrate-rich evening meals on the
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evening before each visit. Body weight and height were measured
by standard procedures.
Insulin sensitivity was assessed by use of frequent sampling 3-
hour oral glucose tolerance tests (OGTTs) where subjects ingested
a solution of 75 g glucose dissolved in 300 mL water. Venous
blood samples were collected before and during the OGTT at
210, 30 and 120 minutes into 4 mL EDTA-coated tubes (BD
Medical, Albertslund, Denmark). The blood was centrifuged at
3000 g at 4uC for 10 min. The plasma fraction was portioned into
2 mL cryotubes (Nunc, Roskilde, Denmark) and stored at 280uC
until further processing.
Chemicals
Authentic standards of PC(18:0/18:2), PC(cis18:1/cis18:1), trans
PC(trans18:1/trans18:1), PC(18:0/18:2), PC(18:0/20:4), PC(18:0/
22:6), PC(17:0/0:0), PC(17:0/17:0), PE(17:0/17:0), PG(17:0/
17:0), Cer(d18:1/17:0), PS(17:0/17:0), PA(17:0/17:0) were pur-
chased from Avanti Polar Lipids Inc. (Alabaster, AL, USA).
Standards of racemic MG(17:0/0:0/0:0), racemic DG(17:0/17:0/
0:0), TG(17:0/17:0/17:0), PC(16:1/0:0-D3), PC(16:1/16:1-D6),
and TG(16:0/16:0/16:0-13C3) were purchased from Larodan
Fine Chemicals AB (Malmo¨, Sweden).
LC-QTOF-MS analysis
Plasma protein precipitation was performed, as described earlier
[14]. An ultra-performance liquid chromatography (UPLC) system
coupled to quadruple time-of-flight (Premier QTOF) mass
spectrometer (Waters Corporation, Manchester, UK) was used
for sample analysis. The mobile phase was 0.1% formic acid in
water (A) and 0.1% formic acid in 70% acetonitrile and 30%
methanol (B). Five mL of each sample were injected into a HSS T3
C18 column (2.16100 mm, 1.8 mm) coupled with a VanGuard
HSS T3 C18 column (2.165 mm, 1.8 mm) operated for 7.0 min.
The eluate was analyzed by electrospray ionization (ESI)-QTOF-
MS (Premium QTOF, Waters) in positive and negative mode,
applying a capillary voltage of 3.2 kV and 2.8 kV, respectively and
cone voltage of 20 kV. Ion source and desolvation gas (nitrogen)
temperatures were set at 120 and 400uC, respectively. More
detailed UPLC-QTOF analysis conditions were explained previ-
ously [15]. Blanks (5% of acetonitrile:methanol 70:30 v/v in water)
and external metabolomics standard mixtures were injected every
30 plasma samples throughout each analytical batch.
In order to identify relevant metabolites, MS/MS fragmenta-
tion analyses were performed by post-column infusion experiments
conducted as follows: a 1.6 mM solution of lithium formate
dissolved in water-propanol (1:1) was infused at 4 uL/min using a
Waters built-in syringe pump. Both flows, from the UPLC column
and the infusion pump, were combined using a zero-dead-volume
‘T’ union and introduced into the mass spectrometer. The MS/
MS experiment was conducted in positive ion mode operating in
product ion scan. The collision-induced dissociation (CID) energy
was set at 25 eV and the MS/MS scan range at m/z 100-850. All
other parameters were set to the same values with the MS
experiment.
In order to verify the findings of lipophilic markers, we
performed a lipidomics analysis of 12 samples from each treatment
group at baseline and at the end of the intervention. Each sample
was added with the internal standards, PC(17:0/0:0), PC(17:0/
17:0), PE (17:0/17:0), PG(17:0/17:0), Cer(d18:1/17:0), PS(17:0/
17:0), PA(17:0/17:0), racemic MG(17:0/0:0/0:0), racemic
DG(17:0/17:0/0:0) and TG(17:0/17:0/17:0) . The concentration
of each standard was approximately 0.1 mg/sample. The samples
were extracted as described previously [14], but an additional
extraction with 200 uL chloroform:methanol (2:1 v/v) was
performed on the SiroccoR filter support by gentle shaking with
the precipitated protein for 5 min followed by opening of the
valves to collect the additional extract. The combined extract was
evaporated to dryness and redissolved in 190 uL water-saturated
chloroform-methanol (2:1). Before injection 0.1 mg of the following
additional standards were added in 10 mL of the same solvent:
PC(16:1/0:0-D3), PC(16:1/16:1-D6), and TG(16:0/16:0/16:0-
13C3), as described by Nygren et al (2011). The samples were
injected on the UPLC-QTOF system using a HSS T3 C18 column
(2.16100 mm, 1.8 mm) coupled with a VanGuard HSS T3 C18
column (2.165 mm, 1.8 mm). Solvent A was 1% 1 M NH4Ac and
0.1% HCOOH in water and solvent B was acetonitrile:2-propanol
(1:1, v/v), 1% 1 M NH4Ac and 0.1% HCOOH. A 6 min gradient
from 100% A to 100% B was used. A gradient in flow was also
applied starting from 0.2 mL/min, increasing to 0.5 mL/min over
3 min and going back to starting conditions at 10 min with 2 min
re-equilibration time before the next injection.
Identification of lipids. Authentic standards PC(18:0/18:2),
PC(cis18:1/cis18:1), PC(trans18:1/trans18:1), PC(18:0/18:2),
PC(18:0/20:4), and PC(18:0/22:6) were analysed by LC-MS with
sample analysis instrumental conditions. As it was not possible to
purchase the standard compound for each PC and SM, we
developed a simple algorithm to identify the various PCs and SMs
by their retention time and m/z. An increased number of carbon
atoms results in decreased polarity and increased retention time.
In addition, for a PC, SM or lysophosphatidylcholine (LPC) with a
specific carbon number, an increasing number of double bonds in
the fatty acyl chain reduces the retention time. Since each of the
lipid species appear with its Na+ adduct, this information is utilized
to remove irrelevant matches for positive mode data. The samples
were analysed two years prior to the authentic standards which
resulted in +0.1 min linear shift in retention time. Thus, 0.1 min
was added to the retention time of each compound in the data set.
As shown in Figure 1 for PCs, the retention times of authentic
standards were matching almost precisely with the predicted ones
(+0.1 min), thereby validating the model. Equally good matching
was observed for retention times of authentic standard of SM
(36:2) and the observed SM (36:2) (not shown). A few PCs
appeared as two isomers, illustrated in Figure 1, corresponding to
structural differences.
The structural characterization of compounds reflecting TFA
intake was performed by their parent mass information and
characteristic fragments in the CID spectrum of their lithated ions.
PC(18:1/20:3) and PC(18:1/22:5) are identified with two orthog-
onal data; retention time and spectral information. PC(18:1/22:6)
is annotated by the algorithm whereas SM(18:1/18:2) was
characterised by MS/MS analysis using Li infusion. Further
information about spectral fragmentation patterns (MS/MS) of the
PC(18:1/20:3), PC(18:1/22:5), PC(18:1/22:6) and SM(18:1/18:2)
is explained in detail as follows.
The product ion spectrum of lithated [M+Li]+ ions for
PC(18:0/22:6) and PC(18:0/20:4) standards were comparable
with the product ion spectrum of lithated [M+Li]+ ions in samples.
A few PCs appeared as two isomers, illustrated in Figure 1,
corresponding to structural differences of naturally occurring
isomers. The ions arising from loss of trimethylamine [M-59],
ethylene phosphate [M-183] and lithium ethylene phosphate [M-
189] were common fragments for CID spectra of PCs and SMs.
The earlier eluting isomer of PC(38:4) gave rise to the fragment
ions 504.3, 528.3 and 534.3, matching with the potential
fragmentation pattern of PC(18:1/20:3). The ions 504.3 and
528.3 represents the neutral loss of the sn-2 fatty acyl substituent as
a lithium salt [M+Li-R2CO2Li]+ and as a ketene [M+Li-
R29CHCO]+, respectively [25,26]. Moreover, the loss of sn-1
Trans Fat Intake: Metabolomics Based Approach
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fatty acyl as a free fatty acid yielded the ion 534.3 corresponding to
([LPC(20:3)-H2O+Li]+). The later eluting isomer of PC(38:4)
coeluted with our standard, PC(18:0/20:4). MS/MS spectra of the
earlier eluting isomer of PC(40:6) implied contribution of two
species (PC(18:1/22:5) and PC(20:2/20:4)) to a single chromato-
graphic peak. The ions 552.3 and 526.3 resulted from loss of the
sn-1 acyl group as a lithium salt from PC(18:1/22:5) and PC(20:2/
20:4), respectively. The most abundant fragment was arising from
the removal of the sn-1 substituent as a ketene. The later eluting
isomer of PC(40:6) coeluted with our standard, PC(18:0/22:6).
MS/MS fragmentation of PC(40:7) lead to its identification as
PC(18:1/22:6) based on the fragment ions 550.3 ([M+Li-
R19CHCO]+) and 556.3 ([M+Li-R1CO2Li]+). MS/MS fragmen-
tation of the pseudomolcular ion of PC(40:7) [M+H] on a Waters
Synapt supported its identity with fragments 445.3 ([LPC(18:1)-
OH]+), 504.3 ([M+H-R1CO2H] +), 568.3([M+H-R19CHCO]+)
and 522.3 ([M+H-R29CHCO]+). However, the CID spectrum of
SM(36:3) did not reveal any abundant ions that identify the fatty
acyl substituents.
We putatively characterized PC(44:9), which is observed only as
its potassium adduct, and we could therefore not include it into
our prediction model in Figure 1. However, extrapolation of the
model agrees with the observed retention time, 5.34 min.
1H NMR Analysis
Plasma samples were slowly thawed overnight at 4uC. Samples
where then centrifuged 20 min at 12 k RPM and 300 ml plasma
were transferred into a 5 mm NMR tube together with 300 ml of
phosphate buffer at pH 7.4 containing at least 10% w/w D2O and
gently mixed in order to avoid formation of bubbles/foam. 1D
NOESY 1H NMR spectra were acquired on a Bruker DRX
spectrometer (Bruker Biospin Gmbh, Rheinstetten, Germany)
operating at 600,00 MHz for protons (14.09 Tesla) using a TCI
cryo-probe head and equipped with a SampleJet autosampler. All
samples were individually and automatically tuned, matched and
shimmed. FIDs were Fourier transformed using a 0.3 Hz line
broadening. The resulting spectra were automatically phased and
baseline corrected using TopspinTM (Bruker Biospin), and the ppm
scale was referenced towards the TSP peak at 0.00 ppm [16].
Assignment of resonances was done by comparison to literature
values [17].
Data Preprocessing
LC-MS. The raw data was converted to an intermediate
netCDF format with the DataBridgeTM utility provided with the
MassLynx software. MZmine 2.7 [18] was employed for data
preprocessing including the following steps: mass detection,
chromatogram builder, chromatogram deconvolution (local min-
imum search), isotopic peaks grouper, peak alignment (join
aligner) and gap filling. The final outcome from MZmine is a
feature set where each feature is denoted by the mass over charge
(m/z) ratio and a retention time.
MZmine preprocessed data was imported to MATLAB
(Version 7.2, The Mathworks, Inc., MA, US). Peak filtering was
applied based on two criteria. First, if a feature has a reasonable
peak area (.60) in the first run blank sample, it is removed.
Second, if a feature has a peak area lower than 5 (considered as
noise level or gap filling errors), in more than 60% of the samples
within both sample groups (TFA vs. CTR, in this case), it is
excluded (percent rule, [19]).
To remove intra-individual variation, each feature is normal-
ized with the mean of the two recordings (before and after
intervention) for each subject at each OGTT time point (210, 30
or 120 min) [19].
1H NMR. The spectral alignment was performed by the
icoshift algorithm [20]. Only the spectral region between 8.5 and
0.2 ppm was considered, and the spectral region containing the
residual resonance from water (4.7–5.1 ppm) was removed. The
Figure 1. The observed retention time values of identified PCs (empty circles). Filled circles illustrate retention time of the authentic
standards, PC(18:1/18:1), PC(18:0/20:4) and PC(18:0/22:6), confirming the predicted pattern.
doi:10.1371/journal.pone.0069589.g001
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spectral data set was normalized by using probabilistic quotient
normalization [21] and reduced by an in-house implementation of
the adaptative intelligent binning algorithm [22]. Varying bin size,
within the boundaries of minimum 0.002 to a maximum
0.02 ppm, was used, depending on the peak width.
Data Analysis. The PLS_Toolbox (version 6.5, Eigenvector
Research, Inc., MA, US) was used to implement the data analysis.
Initially, principal component analysis (PCA) was applied to
visualize grouping patterns and detection of outliers as an
unsupervised multivariate data analysis method. Then, data was
subjected to partial least squares-discriminant analysis (PLSDA)
for classification purposes. PLSDA attempts to separate two
groups of samples by regressing on a so-called dummy y-vector
consisting of zeros and ones in the PLS decomposition. Permu-
tation test [23] was applied with 1000 random assignments of
classes. The test set sample classification errors were evaluated to
qualify the classification results. Selectivity ratio [24], which
provides a simple numerical assessment of the usefulness of each
variable in a regression model, was chosen as the criteria for
variable selection. Briefly, using the y-vector as a target, PLS
components (in many cases more than one) are transformed into a
single target-projected component. The variance explained by the
target component is calculated for each variable and compared
with the residual variance for the same variable. The ratio between
explained and residual variance, called the selectivity ratio,
represents a measure of the ability of a variable to discriminate
different groups [24].
Data analysis was performed on baseline adjusted metabolite
levels after intervention (w16-w0). Figure 2A illustrates data
structure and the baseline adjustment scheme.
Results
52 eligible overweight women were recruited for this study. A
total of 49 participants completed the study, 24 out of 27 TFA-
treated and 25 out of 25 controls. The test diets provided on
average 28% of the subject’s energy requirements. Self-reported
compliance assessed using study diaries showed that 98% of all test
bread rolls were consumed, with no difference between diet
groups. The presence of elevated trans18:1 residues in RBC
phospholipids determined by a gas chromatography/flame ioni-
zation detection was used as an objective compliance measure
[13]. All subjects in the TFA group had elevated trans18:1 residue
levels at both 8 and 16 weeks of intervention, whereas the control
subjects did not (data published in [13]).
Plasma 1H NMR profiles – extraction of TFA related
patterns
Due to low sample amounts available, 42 NMR spectra were
excluded, leaving 327 spectra (158 for TFA group, 169 for CTR
group) for further analysis. Subsequent to binning, the spectral
data set was condensed into 1493 binned ppm regions.
PLSDA was applied individually for the data (baseline adjusted:
w16-w0) including only one OGTT time point with the aim of
discriminating CTR and TFA groups. The original classifications
errors were barely significantly lower than the permuted ones (not
shown). The classification performance was improved when we
concatenated OGTT time points in the sample direction. The
original and permuted data classification errors are given in Figure
3, none of the permutations had lower classification errors than the
original ones.
The resonances reflecting TFA intake were selected based on
evaluation of selectivity ratios from the PLSDA model (i.e. the
resonances that have high selectivity ratio are more influential in
discriminating between TFA and CTR groups). Annotation of
discriminative resonances revealed elevated unsaturated lipids (d
5.3) and LDL & VLDL (d 1.28), methylenic protons for the TFA
group, and an unassigned quartet (d 3.23) for the CTR group.
Later, we included the measurements at w28 (i.e. 12 weeks after
the end of the intervention). As mentioned earlier in this period all
subjects had been under a weight loss program where the aim was
to reverse the unbeneficial effects of TFA intake. Unlike PLSDA
models on baseline corrected values (w12-w0), revealed no
difference between TFA and CTR groups (classification er-
ror = 0.5). This demonstrates that the observed effects of TFA
intake has been disappeared after weight loss program.
Plasma LC-MS profiles – extraction of TFA related
patterns
Inspection of LC-MS plasma profiles revealed that for 29
samples, many peaks were not apparent and other peaks had very
low intensity. In all, 59 and 60 samples measurements remained
for the TFA and CTR groups, respectively. A total of 2260
features in ESI positive mode and 1689 in ESI negative mode were
detected by MZmine. After exclusion of noise and irrelevant
features, by using blank samples and the percent rule, 767 and 710
features for positive and negative modes, respectively, remained
for data analysis.
Initially, each OGTT time point was analysed individually by
PLSDA with the aim of discriminating CTR and TFA groups.
Permutation tests were applied to investigate potential PLSDA
over-fitting issues. Classification error distributions from models
with 1000 times permuted class identifiers together with the
original classification error are presented in Figure 4. In case there
were no differences between the groups, the expected classification
error would be 0.5. Figure 4 perfectly matches this requirement.
The comparison of classification error of the original model
against the permutations was evaluated on the basis of p-values.
Original classification errors were significantly lower than the
permutations with p-values of 0.01 for TOGTT=210, 0.04 for
TOGTT= 30, and 0.03 for TOGTT= 120 (a=0.05).
Variable selection was performed based on the selectivity ratio
from the PLSDA model using datasets from each OGTT time
point. Features with the highest selectivity ratio were extracted
(Table 1). Many of the discriminating features were common for
the three OGTT time points indicating that TFA related patterns
were not affected by OGTT. Identification of these features (as
described in Materials and Methods section) pointed out that they
were compounds from the lipid classes, PCs and SMs.
A similar variable selection procedure was applied for negative
mode, though PLSDA classification performance was lower
compared to positive mode. Still, identical PC species (Table 1)
were associated with TFA intake (data not shown). However,
SM(36:3) was not detected in the negative mode which could be a
potential reason for the lower classification performance.
Since metabolites responding to the TFA exposure did not seem
to be affected by OGTT, we concatenated the time points into a
new data set, to increase the power of the classification model with
a larger number of samples. In this case each subject was
represented by three time points from OGTT measurements as
illustrated in Figure 2B. Furthermore, as we have already
demonstrated that only lipids were associated with TFA intake,
features from the lipid classes (PC, SM and LPC) were included as
variables (Figure 2B). The idea behind targeting the lipids was to
explore whether only the specific PCs and the SM mentioned in
Table 1 respond to TFA intake or if there are other relevant lipids
that could be blurred due to the large number of variables. The
PCA scores plot is shown in Figure 5. The control group clearly
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separated from the TFA group in the second principal
component. Samples from different time points were quite
spread in both CTR and TFA clusters and none of the
principal components explained OGTT (not shown). Later,
PLSDA was applied to select the main contributing lipids. The
classification errors, sensitivity and specificity of cross validated
samples were 0.04, 0.85 and 0.88, respectively. The calculated
selectivity ratios were the largest for the lipid compounds given
in Table 1 (Figure 6) which were all increased with TFA
intake.
In order to investigate whether the increase in specific lipids is
temporary or remain for longer period, the measurements at w28
(i.e.12 weeks after the end of the intervention) were included. As
mentioned earlier in this period all subjects had been under a
weight loss program. The levels of SM(36:3) and PC(40:7) were
increased at w16 and declined to the levels observed before
intervention (w0) at w28 for the TFA group, whereas there was no
change for the CTR group (Figure 7). The other markers in Table
1 exhibited similar trends (not shown). The standard deviation for
the TFA group was higher at w16, which is related to varying
individual responses to TFA intake despite the identical dose level
for all participants in the TFA group.
Finally, to ascertain that the two major markers identified,
SM(36:3) and PC(40:7), were genuine TFA markers in plasma we
quantified them by a targeted lipidomics analysis of a subset of 12
samples from each group using appropriate internal standards.
Under the lipidomics conditions used here the two markers
emerged as significantly higher by factors of 16–40 in the period
with trans-fat exposure and were very low before intervention or
during control conditions after correction for internal standards.
No other features emerged with similar strong contrasts and other
PCs such as two PC(36:2) isomers did not differ between the two
treatments. Some weaker markers of TFA exposures may possibly
exist but that would need more extensive analysis of the full set to
ascertain.
Discussion
TFA has been banned in Denmark since 2004 and background
levels of TFA in Danish citizens are therefore low, resulting only
Figure 2. Data structure and arrangement scheme. Baseline subtraction (A) concatenation of time points (applied on LC-MS and NMR profiles),
and selection of lipid classes (B) (applied on LC/MS data).
doi:10.1371/journal.pone.0069589.g002
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from residual exposures from ruminant fats [27]. This has made
Denmark an ideal place for an intervention to investigate the
short-term effects of TFA with a low background exposure. The
level of exposure selected for the current study is high but not
unattainable with high intakes of fast foods and snacks in countries
where TFA in foods is not tightly regulated [28]. Several TFAs
exist and in the current study, trans18:1 was almost exclusively
present in the intervention oil [13]. From this well-controlled study
of trans vs. cis C18:1 fat in overweight women we report that both
1H NMR and LC-MS plasma metabolic profiles were altered with
TFA intake. In this as in many other studies consumption of TFA
is related with an increased LDL to HDL ratio, which is
considered as a powerful long-term predictor of cardiovascular
disease [29]. Another outcome from NMR was elevated unsatu-
rated lipid signals for the TFA group, which can be attributed to
an increased level of unsaturated fatty acyl side chains in lipid
species. The fatty acid composition of phospholipids in red blood
cell membranes was reported by Bendsen et al. [13]. Their results
did not reveal any significant alteration between the CTR and
TFA groups with respect to the PUFA (or monounsaturated) fatty
acid levels, except for a different content of TFA. Thus, this
difference may be arising from unsaturation of other lipid groups
such as triglycerides in the lipoproteins. Similarly, an elevated
unsaturation in the NMR spectrum (d 5.3–5.4 and d 1.9–2.5) of
HepG2 cell extracts exposed to TFA was mentioned by Najbjerg
et al. [30] in which they concluded disturbed lipid storage
efficiency with TFA intake.
The LC-MS profiles demonstrated elevated levels of a limited
number of polyunsaturated long chain PCs (PC(40:7), PC(40:6),
PC(38:4)) and of SM(36:3), which has the longest chain and the
highest unsaturation among all detected SMs. Increased double
bond formation was also supported by the NMR results. None of
these markers were affected by the OGTT test, revealing that they
are not necessarily only fasting state markers. TFA intake did not
seem to have long term effects on the composition of plasma lipids,
as their levels at w28 after intervention (after the weight loss
period) were comparable to baseline (w0) levels as shown in Figure
7. We observed here SM(36:3) as a marker of TFA intake. This
SM was present at very low levels in the non-TFA group
indicating that it represents an unusual structure. An increased
level of total plasma SMs has been associated with increased risk of
atherosclerosis [31,32] although the consequence in terms of
cardiovascular risk has been debated [33]. In this study we
observed an increase in only a single, minor SM having two C18
chains with one and two double bonds, respectively, either
SM(d18:2/18:1) or SM(d18:1/18:2). The configuration (cis or
trans) around the double bonds in these markers is unresolved and
Figure 3. Permutation test results for NMR profiles. Class
prediction results for NMR profiles based on test set predictions of
the original labelling compared to the permuted data. P-values were
calculated based on the comparison of classification error of the original
model against the permutations.
doi:10.1371/journal.pone.0069589.g003
Figure 4. Permutation test results for LC-MS profiles at each
OGTT time point. Class prediction results for LC-MS profiles based on
test set predictions of the original labelling compared to the permuted
data assessed using the classification errors. TOGTT =210 (A) TOGTT = 30
(B) TOGTT = 120 (C).
doi:10.1371/journal.pone.0069589.g004
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the atherogenic potential of this specific SM will need further
investigation. There was no correlation between the concentration
of this SM and any other SMs. We speculate that the marker
observed here has a D9 or D 11 trans-fatty sphingosine chain
containing a cis-double bond in the 3-position. This would result
from D7 or D9- and other trans-hexadecanoic acids being a
substrate for the slightly promiscuous serine palmitoyltransferase
(EC 2.3.1.50) [34] to form a 3-ketodehydrosphingosine, which
would then be reduced and acylated by oleyl-CoA followed by
desaturation to form Cer(d18:2/18:1). This ceramide would act as
a precursor to the SM(d18:2/18:1) formed by SM synthase (EC
2.7.8.27). We are not able to see the less polar products postulated
here, not even by lipidomics, but the consequence of this
hypothesis would be that after intakes of trans16:1 fatty acids it
would be possible to observe the formation of a whole series of
sphingolipids containing the unusual D9 or D11- trans- D3-cis
C18:2 and other similar sphingosines with the trans double bond in
other positions. In the current study trans16:1 was below the
detection limit in the diet but it is likely that it is formed by b-
oxidation of D9 or D 11-trans-18:1. In a study of 16:1 ruminant
TFAs, the D9 was the dominating isomer but trans double bond
isomers with the double bond at any carbon from position 3 up to
14 also existed [35]. The identity of our SM(d18:2/18:1) marker
needs to be finally proven in separate studies, and if the assignment
is correct the biological and especially neurological consequence of
changing the usual cis-D3-sphingosines by an aberrant backbone
must be elucidated.
We succeeded in identifying several PCs based on authentic
standards and by a systematic pattern of RTs depending on
chain length and saturation. Based on this pattern we could
identify two PC’s, PC(40:6) and PC(40:7), which were specifi-
cally increased in plasma following dietary TFAs, and PC(38:4),
which tended to be increased as well. These PCs carry a C18:1
acyl side chain in one position and a long-chain PUFA chain in
the other based on their CID fragmentation patterns. Since C20
and C22 acyl side chains in PCs are almost exclusively found in
the sn-2 position in humans [36], it is most likely that the 18:1 is
found in the sn-1 position. TFAs, including trans-vaccenic acid
(D11-trans-18:1), sterically resemble saturated fatty acids and
might therefore substitute for these in the sn-1 position. In
agreement, the preferential incorporation of elaidic acid to the
sn-1 chain of phospholipids has been reported in hepatocytes by
Woldseth et al. [37]. In accordance, Wolf and Entressangles
[38] showed that phospholipids from rat liver mitochondria
modified in vivo had large quantities of elaidic acid esterified at
the sn-1 position. We therefore propose that the species
observed here are PC(trans18:1/22:5), PC(trans18:1/22:6) and
Table 1. Features with the highest selectivity ratio based on PLSDA models.
Measured m/z
Retention
time* (min)
Suggested
Compound
Suggested
Adduct
Monoisotopic
mass
Rank
TOGTT =210
Rank
TOGTT =30
Rank
TOGTT =120
749.5614 5.31 SM(36:3) [M+Na]+ 726.5676 1 1 4
727.5781 5.31 SM(36:3) [M+H]+ 726.5676 2 4 7
832.5887 5.33 PC(18:1/22:6) [M+H]+ 831.5778 3 18 6
810.6072 5.52 PC(18:1/20:3) [M+H]+ 809.5934 4 9 25
854.5728 5.33 PC(18:1/22:5) [M+Na]+ 831.5778 5 2 1
922.5617 5.34 PC(44:9) [M+K]+ 883.6091 12 3 2
856.5728 5.41 PC(18:1/22:5) [M+Na]+ 833.5934 6 5 5
*0.1 min was added to the retention time of each compound.
The importance of each feature was represented by its rank. The rank is based on each features sorted selectivity ratio in descending order.
doi:10.1371/journal.pone.0069589.t001
Figure 5. PC1 vs. PC2 scores plot of LC-MS based lipid profiles.
The LC-MS profiles with concatenated time points including only LPCs,
PCs and SMs as variables. Filled circles: TFA, empty circles: CTR.
doi:10.1371/journal.pone.0069589.g005
Figure 6. Selectivity ratio of each lipid species from the PLSDA
model.
doi:10.1371/journal.pone.0069589.g006
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PC(trans18:1/20:3). This hypothesis is supported by the previ-
ously reported elevated trans-18:1 residue levels in red blood cell
phospholipids in the TFA group [13].
It is well known that TFA incorporate membrane phospholipids
into plasma altering the packing of phospholipid and influencing
the physical properties and responses of membrane receptors
[39,40]. TFA produce membrane properties more similar to
those of saturated chains than those of acyl chains containing cis
double bonds [40]. When incorporated into membrane phos-
pholipids, TFA either replace existing saturated or cis unsatu-
rated acyl chains. Harvey et al. [41] showed that both elaidic
and linoelaidic acid integrated into phospholipids, mainly at the
expense of myristic, palmitic, and stearic acids, without causing
any net gain in total fatty acid levels. In our study, the published
membrane phospholipid levels [13] revealed significantly
decreased stearic acid (P = 0.04) and oleic acid (P = 0.02)
abundance in the TFA group compared to CTR, suggesting
replacement of those with elaidic acid. Although LC-MS based
metabolomics did not show any decrease in PCs having one
saturated fatty acyl chain, elaidic acid-containing specific PCs
potentially increased in the TFA group. Many other researchers
have investigated the variation of fatty acid composition in red
blood cell PCs after TFA intake; however none of them reported
the effect of TFA intake on specific PCs. Here, LC-MS based
metabolomics demonstrated up-regulation of specific PCs with
TFA. Moreover the inter-individual variation in the plasma
level of these markers indicates that a variable response to the
same dose of TFA may exist although any relation of our
current markers to CVD risk needs confirmation in observa-
tional studies.
The TFA markers, PC(trans18:1/20:3), PC(trans18:1/22:4) and
PC(trans18:1/22:5), preferentially integrated into PCs all
contain PUFA in the sn-2 position. There was no difference
in the dietary intake of PUFAs in the two diet groups [13], so
the preferred presence of these specific acyl chains together
with trans18:1 would need an explanation. The two minor
markers have peaks with a RT slightly different from the main,
18:0 containing PC(40:6) and PC(38:4) peaks (Figure 1),
indicating that they may be detectable due to better signal-
to-noise ratio for these specific compounds, but the more
prominent PC(40:7) marker is actually dominating the only
PC(40:7) peak observed and the level in the non-TFA group is
quite low. This is not surprising since this compound in general
would be a minor PC because it violates the general rule of
saturated sn-1 and unsaturated sn-2 acyl chains and because no
C22 fatty acid with seven double bonds exists in human lipids.
Other minor TFA-containing PCs may therefore exist but with
RTs that fall on top of major PCs so that they are not detected
as markers. However, it is still noticeable that PC(40:7) is so
abundant. It forms a large peak comparable to other major
PCs, indicating a facilitated formation. We also found evidence
for the presence of the even longer PC(44:9). These observa-
tions could either indicate that there is a general up-regulation
in the formation of long-chain PUFAs after TFA intake and/or
that these fats are specifically mobilised into PC as a result of
TFA exposure. It has been shown that the acyl chain
distribution is very similar in plasma and erythrocyte mem-
branes, indicating that plasma PCs may be a surrogate marker
for membrane composition. Indeed, most plasma PCs may be
abstracted from the membranes in contact with blood.
Increased formation of long-chain PUFAs has been observed
in adipose tissue membranes in overweight individuals [42],
resulting from increased elongase and desaturase activities.
This phenomenon is likely due to compensation for the
increased fat load in the adipocytes in order for them to
remain functional, despite their enlargement during weight
gain [42]. TFA resembling saturated fatty acids may therefore
negatively affect adipose tissue function leading to a response
similar to that seen during weight gain with increased
formation of long-chain PUFA’s. This is supported also by
an increased unsaturation in the NMR spectra for the TFA
group, yet the FA composition of red blood cell phospholipids
did not show any overall significant increase in PUFA [13].
Further investigation of the PUFA distribution among specific
membrane PCs is therefore needed in order to confirm this
hypothesis.
As previously mentioned, phospholipids containing TFA
behave similar to saturated fatty acids rather than to their cis
monounsaturated isomers. It has been reported that trans-acyl
chains adopt extended configurations similar to saturated acyl
chains, allowing better interaction with the cholesterol mole-
cule compared with their cis analogs [43]. These effects could
be contributing factors in modulating cholesterol homeostasis,
and as such, may be part of the explanation of the elevation of
LDL cholesterol by a TFA-rich diet [43] which was demon-
strated by NMR. Although TFA has properties similar to those
of saturated fatty acids and also substitute for saturated fatty
acids in membrane lipids, it has been confirmed in a meta-
analysis that TFA raises levels of LDL more than an equal
amount of saturated fatty acids. This demonstrates the effect
on LDL levels is much larger when TFAs are compared with
their cis analogs [6].
Figure 7. Normalized intensity for metabolites reflected by TFA
intake. PC(40:7) (A) and SM(36:3) (B) at w0, w16 and w28. The values
are the mean of samples in CTR and TFA groups. Each variable is
normalized with the mean of the 9 recordings (at week 0, 16 and 28
with three OGTT time point recordings) for each subject.
doi:10.1371/journal.pone.0069589.g007
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Conclusions
This study was established to investigate the effect of 18:1
TFA intake on plasma metabolites using an untargeted
approach. As results demonstrate specific lipid molecular
species in plasma were formed as a result of TFA exposure
and all belong to the SM and PC polar lipids that exist in
plasma in equilibrium with the plasma membranes. From
those, SM(d18:2/18:1) and PC(trans18:1/22:6) may be a
general plasma marker of exposure to TFAs. We observed a
variable individual marker response to the same TFA dose
and the consequence of this response variation should be
tested in further studies. We could also confirm that TFA
exposure leads to increased plasma LDL. Further studies with
other specific exposures to 16:1 and 18:2 TFAs would give
further insight into the general and specific lipid markers of
TFA exposure.
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